mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
0.078 |
0.2 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
pandacostat |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |